Unknown

Dataset Information

0

Exacerbation of immune thrombocytopenia following COVID-19 vaccination.


ABSTRACT: There is concern that COVID-19 vaccination may adversely affect immune thrombocytopenia (ITP) patients. Fifty-two consecutive chronic ITP patients were prospectively followed after COVID-19 vaccination. Fifteen percent had no worsening of clinical symptoms but no post-vaccination platelet count; 73% had no new symptoms and no significant platelet count decline. However, 12% had a median platelet count drop of 96% within 2-5 days post vaccination with new bleeding symptoms; after rescue therapy with corticosteroids +/- intravenous immunoglobulin (IVIG), platelets recovered to >30 × 109 /l a median three days later. ITP exacerbation occurred independently of remission status, concurrent ITP treatment, or vaccine type. Safety of a second vaccine dose needs careful assessment.

SUBMITTER: Kuter DJ 

PROVIDER: S-EPMC8239625 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8084604 | biostudies-literature
| S-EPMC8709724 | biostudies-literature
2023-10-13 | GSE220659 | GEO
| S-EPMC8814962 | biostudies-literature
| S-EPMC9744687 | biostudies-literature
| S-EPMC7276755 | biostudies-literature
| S-EPMC10593859 | biostudies-literature
| S-EPMC9348067 | biostudies-literature
| S-EPMC8130498 | biostudies-literature
| S-EPMC8647386 | biostudies-literature